Pk study on fluticasone/ salmeterol combinations (OTT329/214)

• Research type

  Research Study

• Full title

  A Phase I Pilot Pharmacokinetic Study in Healthy Subjects of Fluticasone Propionate/Salmeterol Xinafoate\nCombinations Administered as Dry Powders

• IRAS ID

  178650

• Contact name

  Olufeyikemi Oluwayi

• Contact email

  Olufeyikemi.Oluwayi@quintiles.com

• Sponsor organisation

  Quintiles

• Eudract number

  2015-001191-22

• Duration of Study in the UK

  0 years, 2 months, 15 days

• Research summary

  Not yet available

• REC name

  London - Surrey Borders Research Ethics Committee

• REC reference

  15/LO/0579

• Date of REC Opinion

  20 Apr 2015

• REC opinion

  Favourable Opinion